Today: 9 June 2026
Oracle stock drops nearly 5% as $20B share-sale plan lands and bond debt closes
5 February 2026
2 mins read

Oracle stock drops nearly 5% as $20B share-sale plan lands and bond debt closes

New York, February 5, 2026, 11:17 EST — Regular session.

  • Oracle shares dropped roughly 5% in early trading after investors absorbed fresh details on its equity sale plan and a $25 billion debt offering
  • These steps tie into Oracle’s larger 2026 funding effort, driven by significant cloud infrastructure investments
  • Analysts are focused on dilution risk and if the financing eases an overhang before the upcoming earnings report

Oracle shares dropped 4.9% to $139.54 Thursday morning, following the company’s announcement of a $20 billion stock-sale plan and confirmation that it had completed a $25 billion notes offering.

The drop matters as Oracle works to finance a major data-center expansion without rattling bondholders or shareholders. The key question now: how quickly will the company tap equity, and at what valuation, as it scales up cloud spending?

AI-linked infrastructure trades are also caught in a jittery market. Investors have shown little patience for anything that suggests ongoing capital requirements, even if the revenue potential is solid.

Oracle disclosed in an SEC filing that it launched an “at-the-market” (ATM) program, enabling it to sell shares gradually at current market prices instead of a single lump sum. The company set a cap of $20 billion in total sales proceeds and will pay sales agents commissions up to 0.5% of gross proceeds. Additionally, the filing revealed Oracle completed issuing $25 billion in notes with maturities stretching to 2066. The funds raised are intended for general corporate uses, possibly including capital expenditures, debt repayment, investments, acquisitions, dividends, or buybacks. SEC

Oracle signaled earlier this week it aims to pull in $45 billion to $50 billion in gross cash proceeds in calendar 2026, divided roughly between equity and a one-off issuance of investment-grade senior unsecured bonds. The term “investment-grade” refers to borrowers with stronger credit ratings, and Oracle has emphasized its commitment to maintaining that status. Oracle

Part of the equity side involves equity-linked funding. Oracle launched a $5 billion mandatory convertible preferred offering, featuring a 6.5% dividend and roughly a 25% conversion premium, according to IFR. A mandatory convertible is a preferred share that pays dividends but will convert into common stock eventually, potentially diluting current shareholders.

On Feb. 3, Scotiabank analyst Pat Colville lowered his price target, noting the capital plan “gives Oracle runway through early F28.” However, he flagged “lingering medium-term financing questions remain,” Insider Monkey reported via Finviz. Finviz

UBS analyst Karl Keirstead echoed this view following the company’s disclosures, suggesting the newfound clarity “may serve as a clearing event for the stock.” He also pointed out the risk of dilution, according to a separate repost by Insider Monkey on Finviz. Finviz

Oracle is ramping up investment in Oracle Cloud Infrastructure to handle growing demand from major clients and to take on bigger cloud providers in the AI space. That expansion fuels optimism. But the cost of funding it is the immediate challenge.

The risk is clear: faster share sales amid weakness could fuel dilution worries, overshadowing the “funding clarity” angle. On top of that, if capex outpaces cash flow, ratings could come under pressure again, pushing borrowing costs higher.

Investors will be tracking how quickly shares are issued through the ATM program, if Oracle hints at additional equity-linked financing, and how its new bonds perform in secondary trading. The next major milestone is Oracle’s earnings release scheduled for March 9.

Stock Market Today

  • Eloxx Pharmaceuticals Prices $66 Million Offering, Uplists to Nasdaq
    June 8, 2026, 10:12 PM EDT. Eloxx Pharmaceuticals, a clinical-stage biopharma firm, priced a $66 million public offering including common stock and pre-funded warrants. The offering includes 2.975 million shares at $11 each and warrants for 3.025 million shares priced at $10.99 each. Proceeds will support development of Eloxx's novel small molecule therapies targeting genetic diseases caused by nonsense mutations. Eloxx's shares will begin trading on Nasdaq Capital Market on June 9, 2026, under the ticker ELOX. The deal is led by Leerink Partners and Guggenheim Securities with LifeSci Capital as passive bookrunner. This uplisting to Nasdaq marks a key step in expanding Eloxx's market presence and funding pipeline advancement.

Latest articles

Chip Rally Breaks as Nasdaq Faces Tight Labor Market

Nasdaq rises after hours as chips recover

9 June 2026
Nasdaq jumped 0.86% as chip stocks rebounded, with Intel soaring 11.2% on news Google ordered over 3 million AI chips for 2028, while Apple slid 1.9% after unveiling new AI features. Investors await Wednesday’s May CPI inflation report, which could spark volatility in tech and growth stocks.
Broadcom Stock Rebounds, AI Remains an Open Question for Wall Street

Broadcom Stock Rebounds, AI Remains an Open Question for Wall Street

9 June 2026
Broadcom shares jumped 2.8% to $396.60 as chip stocks rebounded after last week’s $1 trillion sector wipeout, but investors remain cautious after Broadcom’s Q2 revenue missed expectations and the company declined to raise its 2027 AI revenue forecast, fueling concerns that rapid AI growth may not meet Wall Street’s high demands.
BitMine Stock Gains as Ether Holdings Approach 5% Target

BitMine Stock Gains as Ether Holdings Approach 5% Target

9 June 2026
BitMine Immersion Technologies shares jumped 6% after revealing ether holdings climbed to 5.54 million tokens, now 4.59% of Ethereum’s supply, with $9.6 billion in crypto, cash and stakes. The company priced a $273.8 million preferred stock offering, with proceeds possibly funding more ETH purchases and staking. BitMine projects $230 million in annualized staking revenues but warns of risks if ETH or financing falters.
Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

9 June 2026
Mingteng International shares soared 81.3% to $1.94 after the company ended its at-the-market stock sale plan, having raised about $20.6 million in gross proceeds; trading volume hit 24.2 million, dwarfing its $12 million market value, as the move outpaced gains in other U.S.-listed China auto stocks.
Dow Jones drops nearly 300 points as Alphabet AI spending plan rekindles tech jitters
Previous Story

Dow Jones drops nearly 300 points as Alphabet AI spending plan rekindles tech jitters

Applied Materials (AMAT) stock snaps back near $300 as Alphabet AI spend stirs chip-equipment trade
Next Story

Applied Materials (AMAT) stock snaps back near $300 as Alphabet AI spend stirs chip-equipment trade

Go toTop